ChemicalBook > CAS DataBase List > Lamotrigine

Lamotrigine

Product Name
Lamotrigine
CAS No.
84057-84-1
Chemical Name
Lamotrigine
Synonyms
LAMICTAL;LAMOTRIGIN;3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE;6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE-3,5-DIAMINE;LTG;TNFSF;BW-430;PRO726;UNQ391;BW-430C
CBNumber
CB4166704
Molecular Formula
C9H7Cl2N5
Formula Weight
256.09
MOL File
84057-84-1.mol
More
Less

Lamotrigine Property

Melting point:
177-181°C
Boiling point:
503.1±60.0 °C(Predicted)
Density 
1.572±0.06 g/cm3(Predicted)
Flash point:
9℃
storage temp. 
2-8°C
solubility 
DMSO: 20 mg/mL at 60 °C, soluble
pka
5.7(at 25℃)
form 
powder
color 
white
Merck 
14,5353
BCS Class
2
InChI
InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
InChIKey
PYZRQGJRPPTADH-UHFFFAOYSA-N
SMILES
N1C(C2=CC=CC(Cl)=C2Cl)=C(N)N=C(N)N=1
CAS DataBase Reference
84057-84-1(CAS DataBase Reference)
More
Less

Safety

Hazard Codes 
T,Xi,F
Risk Statements 
25-36/37/38-39/23/24/25-23/24/25-11
Safety Statements 
45-36-26-36/37-16
RIDADR 
UN 2811 6.1/PG 3
WGK Germany 
3
RTECS 
XY5850700
HazardClass 
6.1(b)
PackingGroup 
III
HS Code 
29336990
Hazardous Substances Data
84057-84-1(Hazardous Substances Data)
Toxicity
LD50 in mice, rats (mg/kg): 250, >640 orally (Sawyer)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H301Toxic if swalloed

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
Y0001085
Product name
Lamotrigine for system suitability
Purity
European Pharmacopoeia (EP) Reference Standard
Packaging
10 mg
Price
$153
Updated
2025/07/31
Sigma-Aldrich
Product number
Y0001031
Product name
Lamotrigine for peak identification
Purity
European Pharmacopoeia (EP) Reference Standard
Packaging
20 mg
Price
$228
Updated
2025/07/31
Sigma-Aldrich
Product number
Y0001030
Product name
Lamotrigine
Purity
European Pharmacopoeia (EP) Reference Standard
Packaging
15 mg
Price
$236
Updated
2025/07/31
Sigma-Aldrich
Product number
L-019
Product name
Lamotrigine solution
Purity
1.0?mg/mL in methanol, ampule of 1?mL, certified reference material, Cerilliant?
Packaging
1mL
Price
$133
Updated
2025/07/31
Sigma-Aldrich
Product number
BP1097
Product name
Lamotrigine
Purity
British Pharmacopoeia (BP) Reference Standard
Packaging
200MG
Price
$228
Updated
2025/07/31
More
Less

Lamotrigine Chemical Properties,Usage,Production

Description

Lamotrigine, also known by the brand name Lamictal®, is a second-generation antiepileptic drug (AED) manufactured by GlaxoSmithKline in the UK and USA. Lamotrigine is a new mazine, glutamate inhibitor anticonvulsant that significantly reduces the incidence of refractory partial seizures. The drug is reported to produce fewer CNS side effects than diazepam or sodium phenytoin. It is also indicated as add-on therapy for the treatment of generalized seizures not satisfactorily controlled by other anti-epileptics.

Chemical Properties

It is a white to cream coloured powder that is soluble in isopropanol and somewhat soluble in water. It has a melting point of 216-218°C and readily dissolves in organic solvents like benzene, toluene, and hot ethanol.

Originator

Burroughs Wellcome (United Kingdom)

History

The development of lamotrigine began in the early 1980s, accidentally discovered by a group of chemists at the Wellcome Research Laboratory while searching for novel antifolate compounds. Initially synthesized as an antifolate analog, subsequent animal model screening revealed its significant anticonvulsant activity, demonstrating its potential as an antiepileptic drug. In 1980, the Wellcome Foundation filed the first synthetic method and related patent applications for lamotrigine (e.g., European Patent EP 0021121), mentioning researchers such as M. G. Baxter. During clinical development, the efficacy of lamotrigine (trade name: lamotrigine tablets) was confirmed, and it was first launched in Ireland in 1991. Subsequently, it was approved by the U.S. Food and Drug Administration (FDA) for the treatment of epilepsy in 1994. In subsequent studies, the clinical applications of lamotrigine have continued to expand, particularly its efficacy as a mood stabilizer. Researchers such as Richard H. Weissler have advanced the application of lamotrigine in the treatment of bipolar disorder, especially in the maintenance treatment of bipolar depression, through clinical observation and research.

Uses

Lamotrigine is an anticonvulsant that works by Inhibits glutamate release, possibly through inhibition of Sodium, Potassium, and Calcium currents. Used in the treatment of bipolar depression, partial seizures in epilepsy, and generalized seizures of Lennox-Gastaut syndrome. Additionally, it is used for the maintenance treatment of bipolar I disorder and depression.

Definition

ChEBI: Lamotrigine is a member of the class of 1,2,4-triazines in which the triazene skeleton is substituted by amino groups at positions 3 and 5, and by a 2,3-dichlorophenyl group at position 6. It has a role as an anticonvulsant, an antimanic drug, an antidepressant, a non-narcotic analgesic, a calcium channel blocker, an excitatory amino acid antagonist, an EC 3.4.21.26 (prolyl oligopeptidase) inhibitor, an environmental contaminant, a xenobiotic and a geroprotector. It is a member of 1,2,4-triazines, a primary arylamine and a dichlorobenzene.

Preparation

The preparation method of Lamotrigine involves several steps. 2,3-dichlorobenzoic acid is chlorinated to 2,3-dichlorobenzoyl chloride, then reacted with cuprous cyanide, condensed with aminoguanidine, and finally cyclized under the action of potassium hydroxide Lamotrigine.
Two key methods for the synthesis of lamotrigine have been reported.
https://www.sciencedirect.com/topics/chemistry/lamotrigine
A novel process for the synthesis of lamotrigine and its intermediate
https://patents.google.com/patent/WO2007069265A1/en

brand name

Lamictal (Glax oSmithKline).

Therapeutic Function

Anticonvulsant

World Health Organization (WHO)

Lamotrigine is a relatively new antiepilepsy agent acting through stabilization of neuronal membranes and preventing liberation of neurotransmitters.

Biological Functions

Lamotrigine has a broad spectrum of action and is effective in generalized and partial epilepsies. Its primary mechanism of action appears to be blockage of voltagedependent sodium channels, although its effectiveness against absence seizures indicates that additional mechanisms may be active. Lamotrigine is almost completely absorbed from the gastrointestinal tract, and peak plasma levels are achieved in about 2 to 5 hours. The plasma half-life after a single dose is about 24 hours. Unlike most drugs, lamotrigine is metabolized primarily by glucuronidation. Therefore, it appears likely that lamotrigine will not induce or inhibit cytochrome P450 isozymes, in contrast to most AEDs.

General Description

Lamotrigine is an antiepileptic drug belonging in the phenyltriazine class. It is used in the treatment of both epilepsy and as a mood stabilizer in bipolar disorder. Lamotrigine is the first medication since lithium granted Food and Drug Administration (FDA) approval for the maintenance treatment of bipolar type I. It is approved for use in more than 30 countries.

Biological Activity

Anticonvulsant. Inhibits glutamate release, possibly through inhibition of Na + , K + and Ca 2+ currents.

Mechanism of action

Lamotrigine has been found effective against refractory partial seizures. Like phenytoin and CBZ, its main mechanism of action appears to be a blockade of sodium channels that is both voltage- and used-dependent. It also inhibits the high-threshold calcium channel, possibly through inhibition of presynaptic N-type calcium channels, and also blocks glutamate release. The most probable explanation for lamotrigine's efficacy is its ability to produce a blockade of sodium channel repetitive firing. In addition, lamotrigine appears to reduce glutaminergic excitatory transmission, although the mechanism for this action remains unclear.

Pharmacokinetics

Following oral administration, lamotrigine is absorbed rapidly and completely, exhibiting linear pharmacokinetics and modest protein binding (55%). Lamotrigine is metabolized predominantly by N-glucuronidation and subsequent urinary elimination of its major metabolite, the quaternary 2-N-glucuronide (80–90%), the minor 5-amino-N-glucuronide (8–10%), and unchanged drug (8–10%). Lamotrigine's usual elimination half-life of 24–35 hours is reduced to 13–15 hours in patients taking enzymeinducing AEDs. The presence of valproate increases the lamotrigine half-life substantially by inhibiting N-glucuronidation, necessitating a reduction in dose to avoid toxicity. Hepatic disease patients may demonstrate a reduced capacity to for lamotrigine glucuronidation, thus reducing its rate of clearance.

Clinical Use

Lamotrigine is a 5-phenyl-1,2,4-triazine derivative indicated as monotherapy or as an adjunct for partial seizures in adults, as adjunct in patients with Lennox-Gastaut syndrome, and as adjunct for partial seizures in children 2 years of age and older. Lamotrigine may have additional benefit in combating myoclonic and typical absence seizures. It is approved for use in the maintenance treatment of bipolar disorder.

Side effects

The usefulness of lamotrigine is limited by the increased incidence of serious rashes, particularly in children or patients taking valproate. This increase, however, may be attenuated by very slow dose escalation, because most rashes appear within the first 8 weeks of treatment. The drug should be discontinued if a rash appears at any time. Additionally, lamotrigine may be associated with development of myoclonus after 2 to 3 years of drug treatment. Additional common side effects associated with lamotrigine therapy include dizziness, diplopia, headache, ataxia, blurred vision, somnolence, and nausea.

Synthesis

The reaction of the Grignard compound of 2,3-dichloroiodobenzene with CO2 in diethyl ether gives 2,3-dichlorobenzoic acid, which is converted to the corresponding acyl chloride by refluxing with SOCl2. The reaction of 2,3-dichlorobenzoyl chloride with cuprous cyanide and KI in refluxing xylene yields 2,3-dichlorobenzoyl cyanide. Finally, this compound is cyclized with aminoguanidine in DMSO to yield lamotrigine .

Metabolism

Lamotrigine is extensively metabolised in the liver by UDP-glucuronyl transferases and excreted almost entirely in urine, principally as an inactive glucuronide conjugate. It slightly induces its own metabolism. Only about 2% of lamotrigine-related material is excreted in faeces.

storage

Room temperature

References

https://my.clevelandclinic.org/health/drugs/20217-lamotrigine-tablets
https://pubchem.ncbi.nlm.nih.gov/compound/Lamotrigine
https://go.drugbank.com/drugs/DB00555
The_Renal_Drug_Handbook_The_Ultimate

Lamotrigine Preparation Products And Raw materials

Raw materials

Copper(I) Cyanide AMINOGUANIDINE 2,3-Dichlorobenzoic acid 2,3-Dichlorobenzoyl chloride

Preparation Products

More
Less

Lamotrigine Suppliers

Americas 1 Brazil 3 Canada 9 China 340 Colombia 1 Czech Republic 1 Europe 3 France 4 Germany 10 Greece 1 Hungary 1 India 190 Iran 1 Israel 4 Italy 1 Japan 2 Malaysia 1 Mexico 2 Nepal 1 Nigeria 1 Oman 1 Poland 7 Singapore 1 Slovenia 1 South Korea 4 Spain 5 Switzerland 3 The Netherlands 2 United Arab Emirates 1 United Kingdom 21 United States 63 Global 686
Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Fax
001-617-206-9595
Email
sales@chemreagents.com
Country
United States
ProdList
10186
Advantage
62
LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2123
Advantage
70
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
HBCChem, Inc.
Tel
+1-510-219-6317
Fax
+1-650-486-1361
Email
sales@hbcchem.com
Country
United States
ProdList
10648
Advantage
60
Alfa Chemistry
Tel
+1-5166625404;
Fax
1-516-927-0118
Email
Info@alfa-chemistry.com
Country
United States
ProdList
20405
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19552
Advantage
58
Cato Research Chemicals Inc.
Tel
+86-020-81960175-877 4000-868-328
Email
tianwen.zhan@cato-chem.com
Country
United States
ProdList
10404
Advantage
58
Alchem Pharmtech,Inc.
Tel
8485655694
Email
sales@alchempharmtech.com
Country
United States
ProdList
63687
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354;
Email
support@targetmol.com
Country
United States
ProdList
39035
Advantage
58
Protheragen-ING
Tel
+16313385890
Email
info@protheragen-ing.com
Country
United States
ProdList
3868
Advantage
58
TargetMol Chemicals Inc.
Tel
+17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
19962
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58
CarboMer, Inc.
Tel
--
Fax
--
Email
sales@carbomer.com
Country
United States
ProdList
4026
Advantage
67
CacheSyn Inc.
Tel
--
Fax
--
Email
info@cachesyn.com
Country
United States
ProdList
695
Advantage
50
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81
International Specialty Chemicals & Pharmaceuticals, Inc. (ISC&P)
Tel
--
Fax
--
Email
info@ischem.com
Country
United States
ProdList
77
Advantage
58
Interchem Corporation USA
Tel
--
Fax
--
Email
esa@interchem.com
Country
United States
ProdList
469
Advantage
58
CQ INTERNATIONAL CO INC
Tel
--
Fax
--
Email
info@cqici.com
Country
United States
ProdList
76
Advantage
58
Exim-Indis, Inc. (part of Exim Corporation and Indis N.V.)
Tel
--
Fax
--
Email
info@exim-indis.com
Country
United States
ProdList
440
Advantage
58
Jubilant Pharma Holdings Inc.
Tel
--
Fax
--
Email
bd.api@jubl.com
Country
United States
ProdList
39
Advantage
58
Selleck Chemicals LLC
Tel
--
Fax
--
Email
sales@selleckchem.com
Country
United States
ProdList
1848
Advantage
58
TOPCHEM PHARMACEUTICALS LTD
Tel
--
Fax
--
Email
Vinchem@vinchem.com
Country
United States
ProdList
140
Advantage
58
SST Corporation
Tel
--
Fax
--
Email
info@sst-corp.com
Country
United States
ProdList
237
Advantage
38
SHAMROCK INDUSTRIAL CO. LTD.
Tel
--
Fax
--
Email
pharma@shamrockindia.com
Country
United States
ProdList
119
Advantage
43
RIA International LLC
Tel
--
Fax
--
Email
marketing@riausa.net
Country
United States
ProdList
1324
Advantage
50
OChem Incorporation
Tel
--
Fax
--
Email
sales@ocheminc.com
Country
United States
ProdList
6501
Advantage
60
Suven Life Sciences
Tel
--
Fax
--
Email
info@suven.com
Country
United States
ProdList
110
Advantage
50
MedChemExpress
Tel
--
Fax
--
Email
sales@medchemexpress.com
Country
United States
ProdList
6398
Advantage
58
MYLAN LABORATORIES LTD
Tel
--
Fax
--
Email
info@amstock.com
Country
United States
ProdList
179
Advantage
58
Riedel-de Haen AG
Tel
--
Fax
--
Country
United States
ProdList
6773
Advantage
87
TCI America
Tel
--
Fax
--
Email
sales@tciamerica.com
Country
United States
ProdList
6909
Advantage
75
Tecoland Corporation
Tel
--
Fax
--
Email
info@tecoland.com
Country
United States
ProdList
275
Advantage
50
LKT Laboratories, Inc.
Tel
--
Fax
--
Email
info@lktlabs.com
Country
United States
ProdList
2164
Advantage
64
Fragmenta
Tel
--
Fax
--
Email
sales@fragmenta.com
Country
United States
ProdList
1068
Advantage
0
Olinax Inc.
Tel
--
Fax
--
Email
info@olinax.com
Country
United States
ProdList
404
Advantage
50
3B Scientific Corporation
Tel
--
Fax
--
Email
sales@3bsc.com
Country
United States
ProdList
6962
Advantage
56
AlliChem, LLC
Tel
--
Fax
--
Email
sales@allichemllc.com
Country
United States
ProdList
6516
Advantage
60
Cerilliant Corporation
Tel
--
Fax
--
Email
techserv@cerilliant.com
Country
United States
ProdList
1629
Advantage
69
Medical Isotopes
Tel
--
Fax
--
Email
stohler@medicalisotopes.com
Country
United States
ProdList
6181
Advantage
68
ACIC Fine Chemicals Inc.
Tel
--
Fax
--
Email
sales@acic.com
Country
United States
ProdList
492
Advantage
48
Sinova Inc.
Tel
--
Fax
--
Email
sales@sinovainc.com
Country
United States
ProdList
4009
Advantage
58
Arasto Pharmaceutical Chemicals Inc.
Tel
--
Fax
--
Email
commercial@arasto.com
Country
United States
ProdList
23
Advantage
30
A.S Chemical Laboratories Inc.
Tel
--
Fax
--
Email
sales@aschemicals.com
Country
United States
ProdList
89
Advantage
30
Spectrum Chemicals & Laboratory Products
Tel
--
Fax
--
Email
sales@spectrumchemical.com
Country
United States
ProdList
6699
Advantage
77
Beta Pharma, Inc.
Tel
--
Fax
--
Email
sales@betapharma.com
Country
United States
ProdList
6226
Advantage
60
Waterstone Technology, LLC
Tel
--
Fax
--
Email
sales@waterstonetech.com
Country
United States
ProdList
6786
Advantage
30
Altan Corporation
Tel
--
Fax
--
Email
OrderingService@AltanBiochemicals.com
Country
United States
ProdList
1161
Advantage
30
More
Less

View Lastest Price from Lamotrigine manufacturers

HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
Product
Lamotrigine 84057-84-1
Price
US $980.00-750.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
5000
Release date
2024-08-15
Wuhan Boyuan Import & Export Co., LTD
Product
lamotrigine 84057-84-1
Price
US $9.00/KG
Min. Order
1KG
Purity
99%
Supply Ability
50000tons
Release date
2023-07-26
Henan Bao Enluo International TradeCo.，LTD
Product
Lamotrigine 84057-84-1
Price
US $15.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
1000tons
Release date
2023-06-14

84057-84-1, LamotrigineRelated Search:

Lamotrigine N2-Glucuronide 2-AMINO-1-PHENYLETHANOL Dichlormid Dichlorodiphenylsilane Dichloromethylphenylsilane 1,3,5-Triazine 3-Dechloro-4-chloro Lamotrigine (Z)-[cyano(2,3-dichlorophenyl)methylene]carbazamidine 2,3-Dichlorobenzoic acid LaMotrigine IMpurity D Lamotrigine N2-Oxide 2,4-Dichlorobenzoyl Cyanide Lamotrigine Impurity 3 2,3-Dichlorobenzoyl cyanide (E)-3-[cyano(2,3-dichlorophenyl)methylene]carbazamidine N-ethylpropane-1,3-diamine Lamotrigine Impurity 4 LaMotrigine Related CoMpound D

  • 4-triazine-3,5-diamine,6-(2,3-dichlorophenyl)-2
  • BW-430C
  • LAMICTAL
  • LAMOTRIGIN
  • LAMOTRIGINE
  • LAMOTRIGINE-13C1
  • GI 267119X
  • Lemotrigine
  • (2,3-Dichloro Phenyl)-1,2,4-triazine-3,5-diamine
  • 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine, LTG, BW-430C, Lamictal
  • 1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-
  • LAMOTRINGINE
  • 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine, GI 267119X
  • 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE
  • 6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE-3,5-DIAMINE
  • LTG
  • BW-430
  • Lamotrigine 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine
  • Lamotrigine (100 mg)
  • LaMotrigine API
  • LaMotrigine、3,5-DiaMino-6-(2,3- dichlorophenyl)-1,2,4-triazine
  • Lamotrigine solution
  • ORGANIC CHEMICAL, LAMOTRIGINE
  • Lamotrigine, 1000ppm
  • Lamotrigine, 98%, a novel anticonvulsant drug for inhibition of 5-HT
  • Lamotrigine for peak identification CRS
  • Lamotrigine&gt
  • Lamotrigine for system suitability CRS
  • Lamotrigine CRS
  • Lamotrigine USP/EP/BP
  • Hot selling Lamotrigine
  • Lamictal XR
  • Lamotrigine (BW430C
  • Lamotrigine, ≥98%
  • Lamotrigine 13C D3Q: What is Lamotrigine 13C D3 Q: What is the CAS Number of Lamotrigine 13C D3 Q: What is the storage condition of Lamotrigine 13C D3 Q: What are the applications of Lamotrigine 13C D3
  • Lamotrigine 13CQ: What is Lamotrigine 13C Q: What is the CAS Number of Lamotrigine 13C Q: What is the storage condition of Lamotrigine 13C Q: What are the applications of Lamotrigine 13C
  • LamotrigineQ: What is Lamotrigine Q: What is the CAS Number of Lamotrigine Q: What is the storage condition of Lamotrigine Q: What are the applications of Lamotrigine
  • Lamotrigine (1356756)
  • 2H3,13C]-Lamotrigine
  • (S)-5-(2-Aminopropyl)-2-methoxy benzenesulfonamide hydrochloride
  • LTG|||BW430C
  • Lamotrigine USP/BP/EP
  • Lamotrigine in methanol
  • Lamotrigine, 10 mM in DMSO
  • LAMOTRIGINE USP (NON-STERILE DRUG SUBSTANCE)
  • LAMOTRIGINE USP
  • Lamotrigine - Bio-X ?
  • Recombinant Human TNFSF14/LIGHT Protein (mFc Tag)
  • PRO726
  • UNQ391
  • TNFSF
  • Tumor necrosis factor ligand superfamily member
  • Member 14) ELISA Kit
  • Uncoated Human TNFSF14 (Tumor Necrosis Factor Ligand Superfamily
  • Lamotrigine 100 μg/mL in Acetonitrile
  • Lamotrigine 1.0 mg/ml in Methanol
  • Lamotrigine, 1mg/ml in Ethanol
  • 84057-84-1